IRIS
COSTA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.762
NA - Nord America 2.369
AS - Asia 1.922
SA - Sud America 627
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.300
RU - Federazione Russa 2.235
SG - Singapore 857
BR - Brasile 526
IE - Irlanda 410
CN - Cina 389
IT - Italia 315
HK - Hong Kong 258
SE - Svezia 229
VN - Vietnam 160
DE - Germania 133
FR - Francia 84
FI - Finlandia 71
IN - India 65
GB - Regno Unito 63
PL - Polonia 61
AT - Austria 48
AR - Argentina 36
MX - Messico 34
BD - Bangladesh 27
CA - Canada 27
MA - Marocco 25
TR - Turchia 24
ES - Italia 21
ZA - Sudafrica 20
NL - Olanda 19
ID - Indonesia 18
IQ - Iraq 18
UA - Ucraina 18
UZ - Uzbekistan 18
EC - Ecuador 16
BE - Belgio 14
CO - Colombia 14
PK - Pakistan 13
JP - Giappone 11
TN - Tunisia 10
KE - Kenya 9
LT - Lituania 9
PY - Paraguay 9
EG - Egitto 8
MY - Malesia 8
AZ - Azerbaigian 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 5
IL - Israele 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
SA - Arabia Saudita 5
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
LB - Libano 4
PE - Perù 4
AL - Albania 3
DK - Danimarca 3
JM - Giamaica 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
DZ - Algeria 2
GY - Guiana 2
HR - Croazia 2
MT - Malta 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
VC - Saint Vincent e Grenadine 1
Totale 8.771
Salva come PNG Salva come JPEG
Città #
Moscow 654
Ashburn 556
Singapore 428
Dublin 410
Dallas 274
Hong Kong 254
Chandler 186
Nyköping 165
San Jose 134
Messina 114
Beijing 105
The Dalles 92
Los Angeles 73
Ho Chi Minh City 62
Warsaw 58
Munich 57
New York 50
São Paulo 47
Lauterbourg 45
Hanoi 33
Dearborn 31
Vienna 31
Bremen 26
Jacksonville 26
Princeton 26
Redondo Beach 26
Rome 26
Ann Arbor 25
Buffalo 24
Tianjin 24
Medford 23
Phoenix 23
Des Moines 22
Helsinki 19
London 19
Santa Clara 19
Shanghai 19
Tashkent 18
Turku 18
Chennai 17
Frankfurt am Main 17
Rio de Janeiro 17
Denver 16
Belo Horizonte 15
Brasília 15
Guangzhou 15
Milan 15
Boardman 14
Brussels 14
Lappeenranta 14
Nuremberg 14
Orem 14
Amsterdam 13
Brooklyn 13
Houston 13
Montreal 13
Chicago 12
Cambridge 10
Campinas 10
Manchester 10
Mexico City 10
Porto Alegre 10
Springfield 10
Tokyo 10
Boston 9
Catania 9
Council Bluffs 9
Düsseldorf 9
Pune 9
Stockholm 9
Atlanta 8
Hillsboro 8
Jakarta 8
Nairobi 8
Nanjing 8
Quito 8
Salvador 8
San Marcellino 8
Ankara 7
Da Nang 7
Goiânia 7
Hyderabad 7
Johannesburg 7
New Delhi 7
Newark 7
San Francisco 7
Shenzhen 7
Washington 7
Baghdad 6
Baku 6
Curitiba 6
Fort Worth 6
Los Lunas 6
Mumbai 6
Poplar 6
San Mateo 6
Seattle 6
Tunis 6
Altoona 5
Asunción 5
Totale 4.831
Salva come PNG Salva come JPEG
Nome #
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 250
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 202
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 183
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 181
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 181
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 180
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 178
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 174
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 171
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 167
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 159
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 156
P1468Non-invasive myocardial work indices in ischemic heart disease 155
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 152
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 151
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 149
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 149
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 145
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 137
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 130
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 128
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 127
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 126
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 125
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 122
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 120
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 119
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 119
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 118
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 116
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 114
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 114
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 109
Left Main Coronary Artery 109
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 108
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 106
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 106
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 106
The High Bleeding Risk Patient with Coronary Artery Disease 104
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 103
Mental health status and sexual habits in young patient after acute coronary syndrome 103
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 99
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 99
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 95
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 94
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 93
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 92
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 92
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 92
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 88
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 88
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 85
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 83
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 80
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 80
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 79
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 79
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 79
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 76
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment 75
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 73
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 73
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 69
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 69
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol 64
Catheter-based techniques for pulmonary embolism treatment 63
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 62
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 62
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization 56
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 56
Vacuum-assisted thrombectomy of massive inferior vena cava thrombosis 48
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 46
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 44
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 43
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 42
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 37
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care 35
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 35
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 33
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 28
null 28
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 28
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 26
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke 26
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 24
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 23
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 23
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 22
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 22
Transfusion and Mortality After Transcatheter Aortic Valve Replacement 22
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 22
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 21
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI 21
Inhibidores selectivos de la recaptacion de serotonina y riesgo hemorragico tras ICP. Un estudio con puntuacion de propension 21
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 20
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19 19
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies 19
DAPT After PCI in High Bleeding Risk 18
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score 17
Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE) 17
Totale 8.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 38 4 6
2021/2022207 2 15 15 6 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024340 21 27 17 39 24 73 70 16 8 21 1 23
2024/20251.696 20 14 16 150 110 135 74 220 368 126 155 308
2025/20265.379 345 313 407 417 463 1.175 619 715 653 272 0 0
Totale 9.052